Aromatase inhibitors: the next generation of therapeutics for endometriosis?

Erkut Attar, Serdar E Bulun
Fertility and sterility · 2006 · vol. 85(5) , pp. 1307–1318 · doi:10.1016/j.fertnstert.2005.09.064 · PMID:16647373 · W2009015643
review OA: bronze CC0 ⤵ 140 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reviews the potential of aromatase inhibitors as a novel therapeutic strategy for managing endometriosis by reducing estrogen production.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Aromatase Inhibitors Aromatase Inhibitors Endometriosis Estrogen Antagonists Estrogen Antagonists Practice Patterns, Physicians' Aromatase Inhibitors Clinical Trials as Topic Endometriosis Estrogen Antagonists Female Forecasting Humans Practice Patterns, Physicians' Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (94)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:18.313808+00:00
License: CC0 · commercial use OK